TickerFactsScreenerDevelopers

CRISPR Therapeutics AG (CRSP) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2015: -$29.10M2016: $232.85M2017: $187.83M2018: $392.19M2019: $939.42M2020: $1.66B2021: $2.40B2022: $1.88B2023: $1.88B2024: $1.93B2025: $1.92B$1.92B
2015Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$1.92B-0.5%
2024$1.93B+2.6%
2023$1.88B+0.4%
2022$1.88B-21.8%
2021$2.40B+44.2%
2020$1.66B+77.2%
2019$939.42M+139.5%
2018$392.19M+108.8%
2017$187.83M-19.3%
2016$232.85M+900.2%
2015-$29.10M—